Table 3.
Main outcome variables and adjuvant therapies in the two study groups
| Variables | EIT group N = 61 |
Control group N = 56 |
p value |
|---|---|---|---|
| Clinical outcome | |||
| 28-day mortality (n, %) | 13 (21%) | 15 (27%) | 0. 634 |
| Ventilator-free days at day 28 (D) | 14.0 (0.0, 23.0) | 18.5 (0.0, 24.0) | 0.764 |
| Length of ICU stay (D) | 13.0 (7.0, 25.0) | 10.0 (7.0, 14.8) | 0.169 |
| ΔD1 SOFA score | 0 (− 1, 1) | 0.5 (− 1, 2.75) | 0.021* |
| ΔD2 SOFA score | − 1 (− 3.5, 0) | 1 (− 2, 2) | < 0.0001* |
| Successful extubation (n, %) | 30 (49%) | 31 (55%) | 0.629 |
| Tracheostomy (n, %) | 17 (28%) | 11 (20%) | 0.409 |
| Adjuvant therapy | |||
| Neuromuscular blocker (n, %) | 12 (20%) | 5 (9%) | 0.166 |
| Prone position (n, %) | 30 (49%) | 23 (41%) | 0.487 |
| Glucocorticoid therapy (n, %) | 11 (18%) | 6 (11%) | 0.390 |
*p < 0.05